Synthesis and Evaluation of Functionalized Aryl and Biaryl Isothiocyanates against Human MCF‐7 Cells
作者:Claire C. Fanta、Kaitlyn J. Tlusty、Sarah E. Pauley、Amanda L. Johnson、Genevieve A. Benjamin、Taylor K. Yseth、Michaela M. Bunde、Paul T. Pierce、Shirley Wang、Peter F. Vitiello、Jared R. Mays
DOI:10.1002/cmdc.202200250
日期:2022.7.19
properties of isothiocyanate 160 against MCF-7 cells after 24 h and 72 h incubation are shown. The plots depict data acquired via antiproliferation and ARE-induction assays; the area below ARE-induction data is shaded to improve clarity (t=24 h, light gray). The results of this study led to the identification of several key structure-activity relationships, as well as lead isothiocyanates demonstrating
Recently, 1,3-diarylalkyl thioureas have merged as one of the promising nonvanilloid TRPV1 antagonists possessing excellent therapeutic potential in pain regulation. In this paper, the full structure-activity relationship for TRPV1 antagonism of a novel series of 1,3-diarylalky thioureas is reported. Exploration of the structure- activity relationship, by systemically modulating three essential pharmacophoric regions, led to six examples of 1,3-dibenzyl thioureas, which exhibit Ca2+ uptake inhibition in rat DRG neuron with IC50 between 10 and 100 nM.